Suzuki et al23 discovered recurrent MYB rearrangement in both pediatric and adult BPDCN patients, with a frequency of 100% and 44%, respectively, however this was based on a very low number of patient population. Here, MYB is linked to CD4+/CD56+ hematodermic neoplasm.